Wednesday, October 23, 2019
News
NEWS HOME
»
PRESS RELEASES

French Biotech CellVax is Now Able to Propose Preclinical Studies in Large Animals
  SocialTwist Tell-a-Friend  
   


Date: 17-04-2019 11:27AM
Source: CellVax
Category: General, Science & Research, Healthcare & Biotechnology, Medical Devices, Pharmaceutical
Location: Maison-Alfort, France

Business Wire India

  • CellVax announces it has signed strategic partnership with 2 large Chinese pharmaceutical companies: Medtech OSMUNDA, a worldwide leading clinical trial CRO and service provider of medical devices, and big pharmaceutical actor: Guangzhou General Pharmaceutical Research Institute.
  • CellVax is now able to propose to its European customers new standards for preclinical and clinical studies, with large nonrodent animals models
  • Qualifying strategy to meet international standards of scientific quality control
  • Public & private financing underway to support CellVax’s strong growth.

Thanks to this strategic partnership, CellVax can now respond to the strong demand for optimal selection of models that represent the human disease best and is ableto offer preclinical studies in large nonrodent species as well as diversified preclinical models or clinical trials.
Large animal models are essential for the development of novel therapeutics for Cancer and Osteoarthritis (OA) fields, the two research specialties of CellVax. Through this partnership, the company has achieved a significant progress in its capacity to provide wide range of animal models for these diseases.
From now on, CellVax offers to fully realize high value-added projects in China and France / Europe, including product registrations in China for European clients, or a better understanding of European markets for Chinese clients.

Quicker funding to support the growth and to finance quality and R&D resources, innovation driver for CellVax
Since February 2019, CellVax has made a strong commitment to enhance the quality of its preclinical studies. Currently, one large GLP toxicology and Bio-distribution study is ongoing at CellVax.
By the end of 2019, CellVax will be able to perform a full range of GLP-compliant preclinical studies in large and small animals for the development of drugs, vaccines and medical devices.

Furthermore, CellVax is fully invested in numerous large-scale European collaborative research programs such as Eureka, FP-7, and Horizon 2020, as well as in the search for new ways of private / public financing in order to continually enhance its R&D capability and to increase its visibility worldwide.

About CellVax – www.cellvax-pharma.com
Founded in 2001, Cellvax is a preclinical Contract Research Organization (CRO) which provides innovating drug validation studies both in vitro and in vivo allowing to accelerate the drug development process for unmet needs related to severe human diseases, mainly in Cancer and Osteoarthritis fields. In addition to preclinical studies, CellVax provides high quality consulting services in order to optimize the discovery process of candidate compounds.



CONTACTS :

CELLVAX
Dr. Mingxing WEI, CEO
+33 (0) 671434751 (France) +86 182 271 08395 (China)
contact@cellvax-pharma.com

FIN’EXTENSO
Press Relations
Isabelle Aprile
+33 1 39 97 61 22
i.aprile@finextenso.fr

More Press Releases

Almond Branding Is Now India's Best Packaging Design Studio

Rubicon Project Acquires RTK.io, A Leader in Open Source Header Bidding Solutions

ResMed Introduces AirFit N30, World’s First Tube-Down Nasal Cradle CPAP Mask

J.P. Morgan Commits USD $25 Million to Help Develop Skills Needed by India’s Workforce in the Future; Announces USD $10 Million Collaboration With World Bank

Mavenir Demonstrates Automated Deployment of Cloud-Native 5G Core at MWC LA

The 4th Edition of UNESCO-Merck Africa Research Summit– MARS 2019 to Be Conducted by Merck Foundation in Accra, Ghana

National Committee on Textiles & Clothing (NCTC) Proposes Measures to Boost the Textile and Clothing Industry

Wipro Selected as Dow Jones Sustainability World Index (DJSI) Member for the Tenth Consecutive Year

Enjoy a Fresh and Clean Diwali Season With HiCare's Services

Beverage Carton Industry Joins Forces Globally to Drive Action on Sustainability

AROMA BIT Secures 350mn JPY in Series A Funding from Japan Tobacco and East Ventures

Alibaba Kicks Off 2019 11.11 Global Shopping Festival

Delhi’s Vivaan Gupta Becomes the Youngest Indian to Travel All Continents of the World

Growing Sustainability Concerns Will Shape the Indian Soft Drinks Industry

Retrospective Real-World Comparative Analysis Highlights Safety of Vedolizumab and Anti-TNFa Therapies in Biologic-Naïve Patients with Ulcerative Colitis or Crohn’s Disease

ADX Group Announces IPO Progress, New Cyber Security Offerings

Delta Launches Its Latest Power Quality Solutions and 4K Laser DLP® Video Wall for Railway Transportation at IREE 2019

Kartik Mohindra Now a Part of Keepers of the Quaich, a Global Celebration of Scotch Whisky

Topcoder On-Demand Digital Talent Platform Includes New Data Science, AI Features to Advance Enterprise Analytics

Marconi Society's Celestini Program Recognizes Indian Students Tackling Women's Safety & Air Pollution

Market Leading Manufacturing Companies in India Recognized for Their Global Competitiveness

Winners of “Merck More Than a Mother” Fashion Awards - Zambia Announced by Merck Foundation With the Aim to Break the Stigma Around Infertile Women

Raysut Cement Subsidiary, Pioneer Cement, to Develop USD200 Million Georgia Cement Project

 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
No question of setting up detention cent...
Sonia Gandhi meets DK Shivakumar in Tiha...
Killers of Hindu leader Kamlesh Tiwari a...
Meghalaya CM meets Shah over Citizenship...
Hyderabad: Surge in demand of fancy eart...
4-5 Cong, JMM legislators set to join BJ...
More...    
 
 Top Stories
Infosys shares plunge 15% on whistl... 
Delhi Police fail the crime test (I... 
Rajasthan promises free air travel ... 
Karnataka HC directs workers to cal... 
52 kg plastic waste, syringes, coin... 
ED attaches assets worth Rs 2.89 cr... 
Syria's Assad visits Idlib front li... 
Ashwin's county side Nottinghamshir...